Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07110116

Alternate Nostril Breathing With Incentive Spirometry on Lung Function Among Asthma Patients

Comparison of Effects of Alternate Nostril Breathing Exercise With Incentive Spirometer Technique on Lung Functions Among Asthma Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To compare effects of Alternate Nostril Breathing exercise with incentive spirometer on lung functions (forced vital capacity, forced expiratory volume, and peak expiratory flow rate) in Asthma patients.

Conditions

Interventions

TypeNameDescription
OTHERAlternate nostril breathing with Incentive SpirometeryParticipants in experimental group were instructed to close their left nostril by left index finger and inhale through their right nostril for six seconds, then closing the right nostril and holding breath for six seconds. Afterward, they exhaled through the left nostril slowly for six seconds. Next, they inhaled through left nostril, keeping the right nostril closed for six seconds then hold the breath by closing both nostrils for six seconds subsequently, and then exhaled through the right nostril, keeping the left closed for six seconds repeating these steps several times for 10 minutes
OTHERIncentive spirometeryThe control group participants were asked to do breathing exercise with incentive spirometry. The subject is asked to create a tight seal around the mouthpiece and asked to inhale deeply and slowly and the subject would observe the flow meter for visual feedback of his/her effort. At the end of the inspiration the subject is asked to sustain the inhalation 2-3 seconds to facilitate the Inspiratory hold. Subject relaxes the seal around the mouthpiece and exhales. Normal breathing is taken, then the exhalation phase in the incentive spirometry is done and the whole cycle is repeated 5 - 10 times thrice a day over a period 6 weeks

Timeline

Start date
2025-08-20
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2025-08-07
Last updated
2025-09-05

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT07110116. Inclusion in this directory is not an endorsement.